Search the Newsreel

Is Medtronic’s Cannula Recall and CoreMap Investment Altering The Investment Case For Medtronic (MDT)?

In late July 2026, Medtronic voluntarily initiated a Class II recall of specific lots of its DLP One-Piece Pediatric Arterial Cannula after two complaints revealed loose foreign material with trace blood, affecting worldwide distribution including several U.S. states. Around the same time, Medtronic led …

Sanara MedTech Inc. (SMTI) filer’s amended 13G shows exit from share ownership

An amended Schedule 13G filing for Sanara MedTech Inc. (SMTI) indicates that investment advisor Christopher M. Plahm, along with Tall Pines Capital, LLC, and Stonebridge Wealth Management, LLC, no longer beneficially own shares in the company. The filing reports 0 shares owned, representing 0.0% …

Medtide Warns of Sharply Lower Interim Profit but Stresses Order Backlog Strength

Medtide Inc. Announces Appointment of Ding Lijun as Chief Financial Officer, Effective July 31, 2026

SANARA MEDTECH INC : H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $35 FROM $36

H.C. Wainwright has downgraded SANARA MEDTECH INC (SMTI.O) from a "Buy" rating to "Neutral" and simultaneously lowered its target price to $35 from $36. This change in rating and price target reflects the analyst's updated view on the company's prospects. The article reiterates this …

Medtronic PLC stock outperforms competitors despite losses on the day

Shares of Medtronic PLC (MDT) declined by 2.09% to $85.71, ending a five-day winning streak despite a generally strong day for the stock market. The S&P 500 Index rose by 1.66%, and the Dow Jones Industrial Average increased by 1.19%. This performance indicates that …

Medtronic leads $37M investment in ablation mapping startup CoreMap

Medtronic has invested $37 million in CoreMap to accelerate the development of its atrial fibrillation mapping platform. This Series C funding round aims to bring CoreMap's technology, which identifies cardiac sites driving complex arrhythmias for improved ablation treatment, to market faster. The investment highlights …

Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It

Medtronic (MDT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this medical device company have returned +10.5% over …

CoreMap raises $37m in Medtronic-led financing round

CoreMap has secured $37 million in a Series C financing round, led by Medtronic, to advance its electrophysiology mapping system. This funding will accelerate the development of CoreMap's next-generation platform for treating and diagnosing atrial fibrillation (AF) by providing more precise, data-driven insights to …

Is There Now An Opportunity In Sanara MedTech Inc. (NASDAQ:SMTI)?

Sanara MedTech Inc. (SMTI) has seen a significant share price rise and its stock is currently undervalued according to Simply Wall St's valuation model, trading below its intrinsic value of $44.08. The company's earnings are expected to double in the coming years, indicating a …

Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders

Ademi LLP is investigating Sanara MedTech Inc. (Nasdaq: SMTI) regarding its transaction with MiMedx, examining whether public shareholders are receiving a fair price and if the Sanara board fulfilled its fiduciary duties. The investigation focuses on the $35 per share cash-and-stock deal, insider benefits, …

Spectral Medical Inc Revenue Breakdown – TSX:EDT

Sanara MedTech to Be Acquired by MiMedx in $35-Per-Share Cash-and-Stock Merger

Sanara MedTech is set to be acquired by MiMedx in a cash-and-stock merger, valuing Sanara at approximately $35 per share. The deal aims to combine two wound-care businesses and is supported by a concurrent voting agreement from holders of about 38.9% of Sanara's voting …

MiMedx Group (SMTI) details Sanara MedTech buyout and 2027 profit goals

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the proposed sale of Sanara MedTech Inc. (SMTI) to MiMedx Group, Inc. and is encouraging Sanara shareholders to examine their rights and options. The investigation focuses on whether Sanara's board failed to secure the …

MiMedx Group Q2 Earnings Call Highlights

Key Points Interested in MiMedx Group, Inc? Here are five stocks we like better. MiMedx agreed to acquire Sanara MedTech for $35 per share, adding more than $100 million in surgical revenue and approximately $4 billion in addressable market opportunity. The combined company expects …

MiMedx plans Sanara MedTech (SMTI) acquisition and prepares S-4 filing

MiMedx has announced its intention to acquire Sanara MedTech, aiming to create a larger regenerative medicine platform with a broader product portfolio for wound care and surgical applications. The acquisition is expected to close by year-end, pending customary closing conditions and regulatory approval. MiMedx …

Medtronic (NYSE: MDT) EVP Quinn reports 2,069 shares withheld for taxes

Michelle Quinn, EVP, GC and Secretary of Medtronic plc, reported a tax-withholding transaction where 2,069 Ordinary Shares were withheld upon the vesting of restricted stock units. Following this, she directly holds 20,375 Ordinary Shares, which includes 697 shares acquired through dividend reinvestment. This Form …

MIMEDX to acquire Sanara MedTech for $350 million

MiMedx Group Inc. announced its definitive merger agreement to acquire Sanara MedTech Inc. for approximately $350 million. Sanara shareholders will receive $33.00 in cash and 0.4735 shares of MIMEDX common stock per share, representing a 46% premium to Sanara's 30-day volume-weighted average share price. …

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

Reports Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standalone Basis Announces Plans to Acquire Sanara MedTech Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- …

MiMedx agrees to buy Sanara MedTech for $35 a share (SMTI:NASDAQ)

MiMedx has announced an agreement to acquire Sanara MedTech for $35 per share. The deal will provide Sanara shareholders with $33.00 in cash and 0.4735 shares of MiMedx common stock for each share they own. This acquisition represents a significant merger in the medical …

This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Run

Key Points Medtronic underperformed the market over the past five years. But it’s still a compelling turnaround play for value-oriented income investors.10 stocks we like better than Medtronic › Medtronic(NYSE: MDT), one of the world's largest medical device makers, was once a reliable blue …

Medtronic PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh Revenue Breakdown – BMFBOVESPA:MDTC34 – TradingView

This article provides a revenue breakdown for Medtronic PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (MDTC34) based on data from TradingView. It highlights that the "Rest of World" segment contributed the most to revenue, with BRL 97.70 billion last year. The content …

Quantinno Capital Management LP Trims Stake in Medtronic PLC $MDT

Quantinno Capital Management LP significantly reduced its stake in Medtronic PLC by 28.0% during the first quarter, selling 283,724 shares and now owning 730,567 shares valued at $63,304,000. Other institutional investors also adjusted their positions, and 82.06% of Medtronic's stock is held by institutional …

Medtronic PLC $MDT Stock Position Decreased by California State Teachers Retirement System

The California State Teachers Retirement System reduced its holdings in Medtronic (NYSE: MDT) by 2.5% in the first quarter of 2026, selling over 53,000 shares but still retaining a significant stake valued at $176.7 million. Despite this, Medtronic reported strong quarterly earnings and revenue, …

A Look at Medtronic PLC (MDT) After 3.2% Gain -- GF Value $100.0

Medtronic PLC (MDT) shares rose 3.2% today, currently priced at $86.88, significantly below its GF Value™ of $100.02, indicating it is 13.1% undervalued. The company has a GF Score™ of 73/100, suggesting above-average performance, with strong valuation but weak momentum. Insider selling and mixed …

Medtronic Stock Builds Momentum On AI, SPR Deal And Bullish Street

Medtronic (MDT) stock is gaining momentum due to several positive catalysts, including its $650M acquisition of SPR Therapeutics, the deployment of its new Touch Surgery Aide AI platform, and improving regulatory prospects for its renal denervation system. Wall Street analysts maintain a generally bullish …

Cryofocus Medtech (Shanghai) Co. Ltd. Class H Revenue Breakdown – HKEX:6922

Is Medtronic (MDT) Fairly Valued After Its Pediatric Cannula Recall?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Medtronic (MDT) is in focus after a voluntary Class II recall of its DLP One-Piece Pediatric Arterial Cannula, following two complaints about loose foreign material …

Medtronic (MDT) Completes $650 Million SPR Deal And Launches ViaVerte

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Medtronic (NYSE:MDT) has completed its US$650m acquisition of SPR Therapeutics. The company formally launched the ViaVerte system at ASPN 2026, expanding its pain therapy portfolio. The deal …

Medtronic PLC (MDT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Medtronic PLC (MDT), indicating a risk score of 9.76 and ranking 1st in the Healthcare Equipment & Supplies industry. It highlights the company's beta of 0.61, suggesting lower volatility compared to the S&P 500, and includes detailed …

Medtronic PLC (NYSE:MDT) Given Consensus Recommendation of "Moderate Buy" by Analysts

Analysts have issued a consensus "Moderate Buy" rating for Medtronic PLC (NYSE:MDT), with an average 12-month price target of $98.21, significantly above its current trading price of $83.12. The company recently surpassed quarterly earnings and revenue expectations and increased its quarterly dividend to $0.72 …

Medtronic (MDT) Stock May Be Fairly Valued As Shares Sit Near A 5 Year Low

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Medtronic stock is coming off a 5 year period where the share price has fallen about 25%, yet current checks suggest the shares sit …

Is Medtronic (MDT) Undervalued Following Its Pediatric Cannula Recall?

Medtronic (MDT) is currently in focus due to a voluntary Class II recall of its pediatric arterial cannula. Despite a recent recall, the stock is considered undervalued with a fair value of $90.37 per share, compared to its current price of $84.22. The company, …

Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know

Medtronic (MDT) recently saw its stock price rise by 1.21% to $84.22, outperforming the S&P 500's daily gain. The company's earnings per share are projected to increase by 10.32% to $1.39 for the upcoming report on September 1, 2026, with revenue expected to reach …

Sanara MedTech Inc. Revenue Breakdown – NASDAQ:SMTI

Sanara MedTech Inc. (NASDAQ:SMTI) generated $103.12 million in revenue last year, with its Soft Tissue Repair Products segment contributing the most at $91.35 million. The United States was the primary geographic contributor, accounting for the entire $103.12 million in revenue, an increase from $86.67 …